sedotime 45 mg 500 càpsules
sedotime 30 mg 500 càpsules
sedotime 15 mg 500 càpsules
sedotime 30 mg 20 càpsules
sedotime 15 mg 30 càpsules
sedotime 45 mg 20 càpsules
glucantime 1,5 g 10 ampolles 5 ml
بيكالوتاميد تيڤع ١٥٠ ملغ
teva pharmaceutical indust.ltd - bicalutamide 150 mg - tablets - bicalutamide - in patients with locally advanced prostate cancer (t3-t4 any n m0 t1-t2 n+ m0) bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.